Home NDC 51655-756-52 Rosuvastatin Calcium
Product NDC 51655-756
Requested package NDC 51655-756-52
11-digit product format 516550756
Labeler code 51655
Product ID 51655-756_495180de-7ec6-97fa-e063-6294a90adb4d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rosuvastatin Calcium
Dosage form TABLET, COATED
Route ORAL
Labeler Northwind Health Company, LLC
Application ANDA201619
Marketing category ANDA
Marketing start 2021-07-19
Substance ROSUVASTATIN CALCIUM
Active strength 5 mg/1
Pharmacologic classes HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A201619-001 ROSUVASTATIN CALCIUM ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 A201619-002 ROSUVASTATIN CALCIUM ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 A201619-003 ROSUVASTATIN CALCIUM ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 A201619-004 ROSUVASTATIN CALCIUM ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201619-001 ROSUVASTATIN CALCIUM EQ 5MG BASE TABLET / ORAL AB 2016-10-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201619-002 ROSUVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2016-10-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201619-003 ROSUVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2016-10-31 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201619-004 ROSUVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2016-10-31 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 172 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Rosuvastatin Calcium
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ROSUVASTATIN CALCIUM 5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 83MVU38M7Q Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 859424 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51655-756-52 Rosuvastatin Calcium 30 in 1 BOTTLE, PLASTIC TABLET, COATED 30 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51655-756 ROSUVASTATIN CALCIUM TABLET, COATED [NORTHWIND PHARMACEUTICALS, LLC] 3 Current NDC, 1 package rows 20241228_da6bfffb-7b04-b522-e053-2a95a90a4736.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 51655-756-52 51655075652 30 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-756-52) 2021-07-19 No No Current